tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Royalty Pharma, Teva enter agreement to accelerate development of TEV-‘408
PremiumThe FlyRoyalty Pharma, Teva enter agreement to accelerate development of TEV-‘408
2d ago
Teva price target raised to $36 from $32 at Truist
Premium
The Fly
Teva price target raised to $36 from $32 at Truist
7d ago
Teva price target raised, named a top 2026 idea at Jefferies
Premium
The Fly
Teva price target raised, named a top 2026 idea at Jefferies
8d ago
Sagimet Biosciences, TAPI announce global license agreement for  resmetirom
PremiumThe FlySagimet Biosciences, TAPI announce global license agreement for resmetirom
28d ago
Teva price target raised to $35 from $28 at JPMorgan
Premium
The Fly
Teva price target raised to $35 from $28 at JPMorgan
29d ago
FTC investigation prompts Teva request for removal of patents from Orange Book
Premium
The Fly
FTC investigation prompts Teva request for removal of patents from Orange Book
1M ago
Teva price target raised to $31 from $28 at Goldman Sachs
PremiumThe FlyTeva price target raised to $31 from $28 at Goldman Sachs
1M ago
Teva initiated with an Outperform at Scotiabank
Premium
The Fly
Teva initiated with an Outperform at Scotiabank
1M ago
Teva sees cash flow ‘probably around’ $2.7B in 2027
Premium
The Fly
Teva sees cash flow ‘probably around’ $2.7B in 2027
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100